Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ Liver
Liver
26 registered clinical trials studyying Liver —
8 currently recruiting
.
Status
Trial
Sponsor
Phase
Not Yet Recruiting
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor
NCT07444645
M.D. Anderson Cancer Center
N/A
Not Yet Recruiting
3D Liver Volumetry
NCT07297615
Medical University of Graz
N/A
Recruiting
Augmented Reality Real-Time Guidance for MRI-Guided Interventions
NCT07120906
Mayo Clinic
N/A
Enrolling By Invitation
Clinical Trial to Evaluate the Effectiveness and Safety of a Remote Automated Ultrasound Diagnostic System for
NCT06487312
Tongji Hospital
—
Recruiting
The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region
NCT06561529
MDCECRO LLC
N/A
Enrolling By Invitation
AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registe
NCT06364865
Teleflex
—
Completed
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With
NCT06195943
Milton S. Hershey Medical Center
N/A
Not Yet Recruiting
SALT for Patients With Hepatic Cirrhosis
NCT06153914
RenJi Hospital
N/A
Recruiting
Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Min
NCT05879159
M.D. Anderson Cancer Center
N/A
Unknown
Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over Tria
NCT05389241
Universitätsklinikum Köln
N/A
Unknown
Effects of Maternal Smoking on Fetal Liver Circulation
NCT04721782
Bezmialem Vakif University
—
Completed
Relationship Between Contrast Media Volume and Tube Voltage in CT for Optimal Liver Enhancement, Based on Body
NCT03735706
Maastricht University Medical Center
N/A
Unknown
DEBOXA for Inoperable NET Liver Metastases
NCT03881306
Xiangya Hospital of Central South University
Phase 1 / Phase 2
Completed
A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver
NCT01471080
Southwest Hospital, China
N/A
Completed
Hepatic Artery Infusion Pump for NPC Liver Metastases
NCT03876574
Xiangya Hospital of Central South University
Phase 1
Unknown
Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Trans
NCT01201096
University of Jena
—
Terminated
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
NCT01163526
Stanford University
—
Unknown
Estimation of Standard Liver Volume in the Indian Population
NCT01143935
All India Institute of Medical Sciences
—
Completed
Primovist Regulatory Post Marketing Surveillance (PMS)
NCT00924248
Bayer
—
Terminated
Liver Transplantation for Cholangiocarcinoma
NCT00708877
University of Utah
N/A
Completed
Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.
NCT00422838
Foundation for Liver Research
—
Withdrawn
Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patie
NCT00718055
Copenhagen University Hospital at Herlev
—
Completed
Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®
NCT01420211
University Medicine Greifswald
Phase 1 / Phase 2
Unknown
Echocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus Polygeline
NCT00343122
Medical University of Vienna
—
Completed
Safety Study of Pioglitazone Compared To Glyburide on Liver Function
NCT00494312
Takeda
Phase 4
Completed
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
NCT00250796
University of New Mexico
Phase 2